A number sign (#) is used with this entry because of evidence that Aicardi- Goutieres syndrome-1 (AGS1) is caused by homozygous or compound heterozygous. Aicardi-Goutières syndrome (AGS) is an inherited, subacute encephalopathy characterised by the association of basal ganglia calcification, leukodystrophy and. Aicardi-Goutières syndrome (AGS) is a rare genetic disorder that affects the brain , spinal cord and immune system. Learn about symptoms, diagnosis and.

Author: Faezshura Faetaur
Country: United Arab Emirates
Language: English (Spanish)
Genre: History
Published (Last): 13 June 2006
Pages: 11
PDF File Size: 11.51 Mb
ePub File Size: 17.74 Mb
ISBN: 639-9-87092-512-2
Downloads: 55619
Price: Free* [*Free Regsitration Required]
Uploader: Akihn

Extraneurological signs are frequent in AGS. This was suspected from as early as the first clinical description of the disease. A most telling story is provided by Cree encephalitis, an apparent infectious disease present in Cree Indian families Black et alsubsequently proved to be genetic and allelic to AGS1, making Aicardi-Goutieres syndrome the ultimate diagnosis Crow et al Cerebrospinal fluid CSFtaken using a “spinal tap,” can also be tested for increased levels of a specific immune system cell a lymphocytewhich indicates a condition known as akcardi-goutieres lymphocytosis.

Visual Inattention Ocular jerks: Antenatal diagnosis Prenatal diagnosis is feasible through molecular analysis of amniotic fluid or trophoblasts. Treatment of AGS is currently only symptomatic 9 and includes the use of drugs to control epilepsy, the prevention syndrime complications and aicardii-goutieres abnormalities, respiratory physiotherapy to treat lung infections and dietary monitoring to ensure adequate caloric intake.

The build up of nucleic acids, particularly non-degraded ssDNA, 46 occurring in the absence of TREX1 enzymatic activity, could activate the TLR9 toll-like receptors in the endoplasmic reticulum: Akcardi-goutieres cases with prenatal onset with microcephaly, increased cell count syncrome the cerebrospinal fluid, increase of interferon alpha, absence of all known intrauterine infections and with cerebral calcifications manifest at birth, collectively known as pseudo-TORCH, also belong to the Aicardi-Goutieres syndrome complex Reardon et al ; Sanchis et al To define the molecular spectrum of Aicardi-Goutieres syndrome, Rice et al.


Similar microcephaly and intracranial calcification with developmental delay occurs following intrauterine infection but is distinguishable by purpuric rash and associated thrombocytopenia.

In This Article Introduction. This hypothesis explains the phenotypic overlap of AGS with congenital infection and some aspects of SLE, where an equivalent type I interferon-mediated innate immune response is triggered by viral and self nucleic acids, respectively. Published by Oxford University Press. The cytokine interferon alpha usually present in viral infections is elevated in aicardi-goutkeres fluid and blood without presence of infective agents.

Aicardi-Goutieres Syndrome Information Page

Similarly, raised INF-alpha in the CSF is a very specific finding in the first stages of the disease, but its absence some years after the onset does not exclude a diagnosis of AGS. Aicardi-Goutieres Syndrome Information Page.

The main findings in this regard are the presence of microcephaly, aicardi-goutierez diffuse inhomogeneous demyelination with astrocytosis, and multiple microinfarctions in the neocortex and cerebellar cortex suggesting microangiopathy. The main extraneurological symptoms are chilblain-like skin lesions, usually on the fingers, toes and ears. Phenotypic Series Toggle Dropdown.

To ensure adequate nutrition and caloric intake, some infants may require special accommodations for diet and feeding. The material is in no way intended to replace professional medical aiczrdi-goutieres by a qualified specialist and should not be used as a basis for diagnosis or treatment. Another typical feature of the syndrome, reported in the earliest descriptions of AGS, is the presence of white matter abnormalities. Treatment of Aicardi-Goutieres Syndrome is symptomatic and supportive.

In 5 families, Rice et al. In retrospect, this was a seminal paper because interferon alpha in later studies proved to be not an epiphenomenon, but a triggering factor in the whole disease process of Aicardi-Goutieres syndrome.

AGS is a genetic disease with a severe clinical picture. The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.


Aicardi-goytieres Synopsis Toggle Dropdown. Receive exclusive offers and updates from Oxford Academic. Familial calcification of the basal ganglia with cerebrospinal fluid pleocytosis. Their jittery behavior and poor feeding ability mimic congenital viral infection.

Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. Today, genetic tests allow us to confirm the AGS diagnosis in a large proportion of cases.

Aicardi-Goutieres Syndrome

Some patients with AGS1 have chilblain-like lesions that resemble those found in the large German family with chilblain lupus. Cree encephalitis is a familial encephalopathy present in Indian Cree children in Northern Quebec, and it shows many similarities with the most severe forms of AGS progressive microcephaly, cerebral atrophy, calcifications and white matter abnormalities, CSF lymphocytosis and raised levels of INF-alpha, systemic immune abnormalities.

Cerebellar atrophy, brainstem atrophy and hypogenesis of the corpus callosum have also been reported as associated findings in few cases. Congenital glaucoma and brain stem atrophy as features of Aicardi-Goutieres syndrome.

Aicardi-Goutieres syndrome

Children should be monitored for evidence of glaucoma in the first few aicardi-goutires of life, and later for evidence of scoliosis, diabetes, and underactive thyroid. The majority of affected infants are born at full term with normal growth parameters. These genes are involved in the DNA damage response, a defect of which could provoke an inappropriate innate immune response, triggering increased secretion of INF-alpha, ultimately responsible for the main features of the disease.

If the affected child’s mutation is known, then the DNA of foetal cells obtained by chorionic villus sampling at 10—12 weeks of gestation or by amniocentesis 15—18 weeks of gestation can aicardi-foutieres examined for the presence of the same mutation.